Democrats have called for investigations into whether he traded stock based on information he gleaned as a congressman. Last year, Mr. Price bought stock in a company that makes orthopedic implants shortly before introducing legislation that could have protected the company, Zimmer Biomet, from financial losses due to a new federal regulation. The regulation sought to rein in spending on joint replacements for Medicare patients Mr. Priceâ€™s legislation would have delayed its implementation. 